Clinical Trials Browser

Phase NA × cabozantinib × Clear all

NCT02592356 2024-03-05

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Phase NA Completed

Paraganglioma, Extra-Adrenal, Carcinoma, Medullary

NCT01812668 2021-08-05

Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Phase NA Completed

20 enrolled 12 charts

Prostatic Neoplasms